Educational Background
Work Experience
|
Personal Information
Dr. Luqing Zhao, Associate Professor, M.D. & Ph.D., Supervisor of Master's Candidates, Department of Pathology, School of Basic Medical Science, Xiangya School of Medicine, Central South University.
Winners of "Hong Kong Scholars Award" and the "Excellent Doctoral Dissertation Award of Hunan Province".
Bachelor of Clinical Medicine (M.D.) and Doctor of Medicine (Ph.D.) in Xiangya School of Medicine, Central South University. Visiting Scholar and Joint training Ph.D. candidates by Chinese government and USA (Sponsored by China Scholarship Council) in the Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. “Hong Kong Scholar” and Post-doctoral Fellow in the Department of Pathology (State Key Laboratory of Liver Research), Li Ka Shing Faculty of Medicine, The University of Hong Kong. And the Post-doctoral Fellow of Clinical Medicine in Xiangya Hospital, Central South University.
Member of the American Association for Cancer Research (AACR Active Member), Committee Member of the Bio-Trace Element Branch of the Biophysical Society of China (BSC), China Anti-Cancer Association (CACA) Member (Specialized Committee for Tumor Biomarker, Tumor Pathology, and Tumor Metabolism), Executive Director of the Pathology Branch of Hunan Health Service Industry Association, Expert in Dissertation Evaluation of Academic Degree Center of Ministry of Education, and Expert of Science and Technology Project Evaluation in Hunan Province.
The main research interests are tumor pathology, the molecular mechanism of the interaction between cancer stem cells and tumor microenvironment, cancer immunology and so on. Till now, 24 SCI journal papers have been published, including 21 first/corresponding authors (16 papers in JCR Q1 zone). She has presided over and completed multiple research projects, including the National Natural Science Foundation of China (NSFC), Hong Kong Scholars Program Funded Grant, Hong Kong Health and Medical Research Fund (HMRF), China Postdoctoral Science Foundation (First-class), the Natural Science Foundation of Hunan Province and so on.
Served as the Editorial Board Members of 10 international academic journals such as Journal of Clinical and Translational Hepatology (IF: 5.065), Gastroenterology & Hepatology Research, Microenvironment & Microecology Research and so on. She also served as the peer reviewers of 14 international academic journals such as Theranostics, Journal of Experimental & Clinical Cancer Research, Cell Death & Disease, Cell Proliferation and so on.
Academic Titles AACR Active Member China Anti-Cancer Association (CACA) Member (Specialized Committee for Tumor Biomarker, Tumor Pathology, Tumor Metabolism) CACA Youth Council Member Hunan Anti-Cancer Association (HACA) Member Executive Director of Hunan Health Service Association Pathology Branch Expert in Dissertation Evaluation of Academic Degree Center of Ministry of Education Expert of Science and Technology Project Evaluation in Hunan Province 《Journal of Clinical and Translational Hepatology》Editorial Board Member 《Gastroenterology & Hepatology Research》Editorial Board Member 《TMR Cancer》Editorial Board Member 《TMR Aging》Editorial Board Member 《Microenvironment & Microecology Research》Editorial Board Member 《Precision Medicine Research》Editorial Board Member Peer reviewers of international academic journals of 《 Theranostics 》《 Cell Death & Disease 》《 Journal of Experimental & Clinical Cancer Research 》《 Cell Proliferation 》《 Molecular Carcinogenesis 》《 Scientific Reports 》《 Journal of Clinical and Translational Hepatology 》《 Artificial Cells, Nanomedicine, and Biotechnology 》《 Cancer Management and Research 》《 Medical Science Monitor 》《 Cancer Investigation 》
Research Fundings National Natural Science Foundation of China (NSFC) (81602575), “Molecular mechanism of DDX3X regulating miRNA biogenesis to promote invasion and metastasis of breast cancer”, 2017-2019, Principal Investigator Hong Kong Scholars Program Funded Grant (XJ2016054), “Molecular mechanism of the interaction between hepatocellular carcinoma stem cells and tumor microenvironment”, 2017-2019, Principal Investigator Hong Kong Health and Medical Research Fund (HMRF) (06172886), “The functional significance of RalA: Regulations and therapeutic implication in liver cancer”, 2018-2020, Principal Investigator (Co-PI) China Postdoctoral Science Foundation (2016M590756), “Molecular mechanism of DDX3X regulating invasion and metastasis of cutaneous melanoma”, 2016-2019, Principal Investigator Natural Science Foundation of Hunan Province (2017JJ3430), “Molecular mechanism of "DDX3X---miR-19b/miR-20a---MYLIP" axis regulating invasion and metastasis of breast cancer”, 2017-2019, Principal Investigator
Honors and Awards 2016 Hong Kong Scholars Award 2018 Best Oral Presentation Award, Hong Kong Scholars Annual Symposium 2016 Excellent Doctoral Dissertation Award of Hunan Province 2016 Excellent Doctoral Dissertation Award of Central South University 2013 National government-sponsored overseas study scholarship, the China Scholarship Council (CSC)
Academic Conferences The American Association for Cancer Research (AACR) Annual Meeting 2018, Apr 14-18, 2018, Chicago, USA. The Hong Kong Scholars Annual Symposium 2018, March 24, 2018, Hong Kong, Hong Kong. The State Key Laboratory of Liver Research (SKLLR) Internal Research Meeting 2018, March 24, 2018, Hong Kong, Hong Kong. The Theme-Based Research Scheme Project on Liver Cancer Stemness, Oct 24, 2018, Hong Kong, Hong Kong. The Chinese Conference on Oncology (CCO) 2020, Nov 12-15, 2020, Guangzhou, China. The Chinese Academic Conference on Tumor Biomarker 2020, Dec 11-13, 2020, Guangzhou, China. The "Nine schools" Youth Scholars Teaching and Scientific Research Exchange Conference 2019, Nov 22-24, 2019, Fuzhou, China. The "Nine schools" Youth Scholars Teaching and Scientific Research Exchange Conference 2016, March 24-26, 2016, Wuhan, China.
|